Justin B. Klee, Co-CEO: Amylyx Pharmaceuticals AMLX Planned sale · Filed 01/15

Trade details

Type: Planned sale notice
Stock: Amylyx Pharmaceuticals AMLX
Person: Justin B. KleeCo-CEO
Planned sale date: 26/01/15
Filed: 26/01/15

More to sell after $85.6K in 3 months

Amylyx Pharmaceuticals trades, last 26 weeks

What else happened in Amylyx Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 25/12/16~02/14

Justin B. Klee's recent trades

Justin B. KleeCo-CEO
Planned saleAmylyx Pharmaceuticals
Planned sale
Amylyx Pharmaceuticals
AMLX
$980.3K
30,464 sh
$980.3K
Filed 09/11
Traded 09/10
Justin B. KleeCo-CEO
SellAmylyx Pharmaceuticals
Sell
Amylyx Pharmaceuticals
AMLX
$423.7K
29,282 sh
$423.7K
Filed 03/04
Traded 03/02
Justin B. KleeCo-CEO
Planned saleAmylyx Pharmaceuticals
Planned sale
Amylyx Pharmaceuticals
AMLX
$423.8K
29,282 sh
$423.8K
Filed 03/02
Traded 03/02
Justin B. KleeCo-CEO
SellAmylyx Pharmaceuticals
Sell
Amylyx Pharmaceuticals
AMLX
$227.7K
15,500 sh
$227.7K
Filed 02/04
Traded 02/02
Justin B. KleeCo-CEO
Planned saleAmylyx Pharmaceuticals
Planned sale
Amylyx Pharmaceuticals
AMLX
$227.6K
15,500 sh
$227.6K
Filed 02/02
Traded 02/02

Justin B. Klee, CEO — plans to sell 136,193 sh of Amylyx Pharmaceuticals AMLX · $1.9M · around 01/15 | Whalegun